Research Industry Presents United Front On Japan Reforms

Strong IP Waiver Opposition

Three groups representing the domestic and multinational research-based pharma industry in Japan present a unified position as they call for policy changes they see as providing the right environment for investment, innovation and a sustainable healthcare system. 

japandebate
Industry Wants Continued Debate On Japan Policy Reforms • Source: Alamy

More from Japan

More from Asia